These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 10871975

  • 1. Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis.
    Richter JE, Peura D, Benjamin SB, Joelsson B, Whipple J.
    Arch Intern Med; 2000 Jun 26; 160(12):1810-6. PubMed ID: 10871975
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Jun 26; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 3. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D, Paré P, Pericak D, Pyzyk M, Canadian Pantoprazole GERD Study Group.
    Am J Gastroenterol; 2001 Oct 26; 96(10):2849-57. PubMed ID: 11695354
    [Abstract] [Full Text] [Related]

  • 4. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C.
    Arch Intern Med; 2000 Jun 26; 160(12):1803-9. PubMed ID: 10871974
    [Abstract] [Full Text] [Related]

  • 5. Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.
    Galmiche JP, Barthelemy P, Hamelin B.
    Aliment Pharmacol Ther; 1997 Aug 26; 11(4):765-73. PubMed ID: 9305487
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
    Maton PN, Orlando R, Joelsson B.
    Aliment Pharmacol Ther; 1999 Jun 26; 13(6):819-26. PubMed ID: 10383513
    [Abstract] [Full Text] [Related]

  • 7. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS, Rowley JL.
    Aliment Pharmacol Ther; 1996 Oct 26; 10(5):757-63. PubMed ID: 8899084
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE, Kahrilas PJ, Johanson J, Maton P, Breiter JR, Hwang C, Marino V, Hamelin B, Levine JG, Esomeprazole Study Investigators.
    Am J Gastroenterol; 2001 Mar 26; 96(3):656-65. PubMed ID: 11280530
    [Abstract] [Full Text] [Related]

  • 9. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis.
    Bate CM, Green JR, Axon AT, Murray FE, Tildesley G, Emmas CE, Taylor MD.
    Aliment Pharmacol Ther; 1997 Aug 26; 11(4):755-63. PubMed ID: 9305486
    [Abstract] [Full Text] [Related]

  • 10. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T, Schütze K, van Leendert RJ, Fumagalli I, Costa Neves B, Bohuschke M, Gatz G.
    Digestion; 2003 Aug 26; 67(1-2):6-13. PubMed ID: 12743434
    [Abstract] [Full Text] [Related]

  • 11. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.
    Drugs; 2002 Aug 26; 62(7):1091-118. PubMed ID: 11985491
    [Abstract] [Full Text] [Related]

  • 12. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.
    Am J Gastroenterol; 2001 Jan 26; 96(1):27-34. PubMed ID: 11197282
    [Abstract] [Full Text] [Related]

  • 13. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
    Chiu CT, Hsu CM, Wang CC, Chang JJ, Sung CM, Lin CJ, Chen LW, Su MY, Chen TH.
    Aliment Pharmacol Ther; 2013 Nov 26; 38(9):1054-64. PubMed ID: 24024757
    [Abstract] [Full Text] [Related]

  • 14. Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease.
    Delchier JC, Cohen G, Humphries TJ.
    Scand J Gastroenterol; 2000 Dec 26; 35(12):1245-50. PubMed ID: 11199361
    [Abstract] [Full Text] [Related]

  • 15. Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
    Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I.
    J Am Coll Surg; 2001 Feb 26; 192(2):172-9; discussion 179-81. PubMed ID: 11220717
    [Abstract] [Full Text] [Related]

  • 16. Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment.
    Bytzer P, Morocutti A, Kennerly P, Ravic M, Miller N, ROSE Trial Investigators.
    Scand J Gastroenterol; 2006 Oct 26; 41(10):1132-40. PubMed ID: 16990197
    [Abstract] [Full Text] [Related]

  • 17. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.
    Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O.
    Aliment Pharmacol Ther; 2001 Mar 26; 15(3):347-54. PubMed ID: 11207509
    [Abstract] [Full Text] [Related]

  • 18. Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.
    Miner P, Orr W, Filippone J, Jokubaitis L, Sloan S.
    Am J Gastroenterol; 2002 Jun 26; 97(6):1332-9. PubMed ID: 12094846
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group.
    Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ.
    Aliment Pharmacol Ther; 1999 Jan 26; 13(1):49-57. PubMed ID: 9892879
    [Abstract] [Full Text] [Related]

  • 20. Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease.
    Sloan S.
    Am J Gastroenterol; 2003 Mar 26; 98(3 Suppl):S49-55. PubMed ID: 12644031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.